Global Anticancer Drugs Market Research Report 2024
상품코드:1426855
리서치사:QYResearch
발행일:2024년 02월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 항암제 시장 규모는 2023년에 1,900억 1,200만 달러에 달했습니다. 이 시장은 2024-2030년의 예측 기간 중 11.26%의 CAGR로 확대하며, 2030년에는 3,910억 300만 달러에 달할 것으로 예측되고 있습니다.
북미의 항암제 시장 규모는 2023년 1,048억 3,500만 달러에서 2030년에는 2,070억 6,800만 달러에 달할 것으로 예측되며, 2024-2030년의 예측 기간 중 CAGR은 10.7%에 달할 것으로 전망됩니다.
아시아태평양의 항암제 시장 규모는 2023년 395억 1,800만 달러에서 2030년에는 890억 4,200만 달러에 달할 것으로 예측되며, 2024-2030년의 예측 기간 중 CAGR은 12.38%에 달할 것으로 전망됩니다.
항암제의 세계 주요 제조업체에는 Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Amgen, Eli Lilly 등이 있습니다. 2023년, 세계 상위 5사의 판매고 점유율은 약 55.06%였습니다.
세계의 항암제 시장에 대해 조사했으며, 시장의 개요와 기업별, 유형별, 용도별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
목차
제1장 항암제 시장 개요
제품의 정의
항암제, 유형별
항암제, 용도별
세계의 항암제 시장 규모 예측
전제와 제한
제2장 제조업체에 의한 항암제 시장 경쟁
제3장 세계의 항암제 시장 시나리오, 지역별
세계의 항암제 시장 규모 : 2019년 대 2023년 대 2030년, 지역별
지역별 세계의 항암제 매출 : 2019-2030년
북미
유럽
아시아태평양
남미
중동 및 아프리카
제4장 유형별 부문
세계의 항암제 매출(2019-2024년), 유형별
세계의 항암제 매출(2025-2030년), 유형별
세계의 항암제 매출 시장 점유율(2019-2030년), 유형별
제5장 용도별 부문
세계의 항암제 매출(2019-2024년), 용도별
세계의 항암제 매출(2025-2030년), 용도별
세계의 항암제 매출 시장 점유율(2019-2030년), 용도별
제6장 주요 기업의 개요
Abbvie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
GSK
Exelixis
Regeneron
Innovent
Innovent
제7장 산업 체인과 판매채널 분석
항암제 산업 체인 분석
항암제의 주요 원료
항암제의 제조 방법과 프로세스
항암제 판매 및 마케팅
항암제 고객
제8장 항암제 시장 역학
항암제 업계의 동향
항암제 시장 촉진요인
항암제 시장이 해결해야 할 과제
항암제 시장 억제요인
제9장 조사 결과와 결론
제10장 조사 방법과 데이터 소스
KSA
영문 목차
영문목차
The global Anticancer Drugs market was valued at US$ 190,012 million in 2023 and is anticipated to reach US$ 391,003 million by 2030, witnessing a CAGR of 11.26% during the forecast period 2024-2030.
North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the forecast period of 2024 through 2030.
Asia-Pacific market for Anticancer Drugs is estimated to increase from $ 39,518 million in 2023 to reach $ 89,042 million by 2030, at a CAGR of 12.38% during the forecast period of 2024 through 2030.
The global key manufacturers of Anticancer Drugs include Merck & Co, Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Amgen, Eli Lilly, etc. In 2023, the global top five players had a share approximately 55.06% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Anticancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticancer Drugs.
The Anticancer Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anticancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anticancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
GSK
Exelixis
Regeneron
Innovent
Hengrui Medicine
Segment by Type
Chemotherapy
Targeted Therapy
Cancer Immunotherapy
Other
Segment by Application
Lung Cancer
Breast Cancer
Prostate Cancer
Blood-related Cancer
Other
Consumption by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
South America
Brazil
Middle East & Africa
Middle East
Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anticancer Drugs manufacturers competitive landscape revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Revenue of Anticancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Table of Contents
1 Anticancer Drugs Market Overview
1.1 Product Definition
1.2 Anticancer Drugs by Type
1.2.1 Global Anticancer Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Cancer Immunotherapy
1.3 Anticancer Drugs by Application
1.3.1 Global Anticancer Drugs Market Value by Application (2024-2030)
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Prostate Cancer
1.3.5 Blood-related Cancer
1.4 Global Anticancer Drugs Market Size Estimates and Forecasts
1.5 Assumptions and Limitations
2 Anticancer Drugs Market Competition by Manufacturers
2.1 Global Anticancer Drugs Revenue Market Share by Manufacturers (2019-2024)
2.2 Global Key Players of Anticancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.3 Global Key Manufacturers of Anticancer Drugs, Market Area & Headquarters
2.4 Global Key Manufacturers of Anticancer Drugs, Product Type
2.5 Global Key Manufacturers of Anticancer Drugs, Founded Date
2.6 Global Anticancer Drugs Market Competitive Situation and Trends
2.6.1 Global Anticancer Drugs Market Concentration Rate
2.6.2 The Global 5 and 10 Largest Anticancer Drugs Players Market Share by Revenue
2.6.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
